ALOX15B (C-term), 597-627 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-ALOX15B (C-term), 597-627 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityALOX15B (C-term), 597-627
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatpurified
Size0.08 mL, 0.4 mL
Concentrationvial concentration: 2
ApplicationsELISA (EIA), Immunohistochemistry (IHC), Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis ALOX15B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 597-627 amino acids from the C-terminal region of human ALOX15B. ALOX15B encodes a member of the lipoxygenase family of structurally related nonheme iron dioxygenases involved in the production of fatty acid hydroperoxides. The encoded protein converts arachidonic acid exclusively to 15S-hydroperoxyeicosatetraenoic acid, while metabolizing linoleic acid less effectively. This gene is located in a cluster of related genes and a pseudogene that spans approximately 100 kilobases on the short arm of chromosome 17.
Immunogenn/a
Other Names[Arachidonate 15-lipoxygenase B; 15-LOX-B; 15-lipoxygenase 2; 15-LOX-2; Arachidonate 15-lipoxygenase type II; Linoleate 13-lipoxygenase 15-LOb; 11311-; ALOX15B]
Gene, Accession #[ALOX15B], Gene ID: 247, NCBI: NP_001034219.1, UniProt: O15296
Catalog #MBS9200802
Price$165, $370
Order / More InfoALOX15B (C-term), 597-627 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesWecksler,A.T., et.al., Biochemistry 48 (36), 8721-8730 (2009) Kawakami,Y., et.al, Biosci. Biotechnol. Biochem. 73 (8), 1811-1817 (2009)
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.